
Jeffrey H Samet, MD, MA, MPH
Professor, Community Health Sciences - Boston University School of Public Health
Biography
My research has focused on alcohol and drug use, HIV infection and primary medical care with the following specific projects: linkage of alcohol and drug use treatment and primary medical care; addressing alcohol and drug use issues in the primary care setting; the impact of alcohol and drug use in HIV-infected persons; HIV prevention and treatment in Russian substance users; and establishing medical care for HIV-infected persons.
Other Positions
- Professor, Medicine - Boston University Chobanian & Avedisian School of Medicine
- Member, Evans Center for Interdisciplinary Biomedical Research - Boston University
- Faculty, Medicine - Boston University Chobanian & Avedisian School of Medicine
Education
- Baylor College of Medicine, MD Field of Study: Medicine
- Boston University, MPH Field of Study: Epidemiology
- Brandeis University, MA Field of Study: Chemistry
- Brandeis University, BA
Publications
- Published on 6/1/2025
Magane KM, Dukes KA, Fielman S, Palfai TP, Regan D, Cheng DM, Lee H, Kraemer KL, Bullard MJ, Chen CA, Samet JH. Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Intern Med. 2025 Jun 01; 185(6):635-645. PMID: 40257810.
Read At: PubMed
- Published on 4/11/2025
Gilbert L, Chahine R, Chandler R, Feaster DJ, Kim E, Aldridge A, Bagley S, Balvanz P, Fernandez S, Rock P, Vickers-Smith RA, Villani J, Battaglia T, Brown J, Bush H, Chase RP, Collins T, D'Costa L, Damato-MacPherson C, David JL, Defiore-Hyrmer J, Freeman PR, Glasgow L, Hammerslag LR, Hotchkiss J, Hunt T, Hussain S, Kamanu V, Knott C, Knudsen HK, LaRochelle M, Laudate A, Lyons M, McMullan J, Nakayima J, Schackman BR, Slavova S, Tan S, Vandergrift N, Walters ST, Westgate PM, Wu E, Young AM, Zarkin GA, Freisthler B, Oga E, Samet JH, Walsh SL, Winhusen J, Jackson R, El-Bassel N. The effectiveness of the communities that HEAL intervention on reducing non-fatal opioid overdoses: A prespecified secondary analysis of a waitlist cluster control randomized controlled trial. Int J Drug Policy. 2025 Jun; 140:104798. PMID: 40220509.
Read At: PubMed
- Published on 4/3/2025
Jayasinghe T, Drainoni ML, Walley A, Grella C, Majeski A, Rolles A, Cogan A, Venkatesan G, Stein MD, Larochelle M, Samet JH, Kimmel SD. "Every Time I Go in There, It Gives Me Time to Reflect": A Qualitative Study of Patient Perspectives on Substance Use, Medications for Opioid Use Disorder, and Harm Reduction Following Hospitalization for Serious Injection-Related Infection. Open Forum Infect Dis. 2025 May; 12(5):ofaf201. PMID: 40352630.
Read At: PubMed
- Published on 2/11/2025
Fuster D, So-Armah K, Cheng DM, Blokhina E, Patts G, Lioznov D, Gnatienko N, Long MT, Freiberg MS, Tindle H, Samet JH. Is There an Association Between Cigarette Smoking and Advanced Liver Fibrosis in Smokers with HIV, Heavy Drinking and High Prevalence of HCV? J Clin Med. 2025 Feb 11; 14(4). PMID: 40004700.
Read At: PubMed
- Published on 1/29/2025
Bhatraju EP, Kennedy DN, Gojic AJ, Iles-Shih M, Merrill JO, Samet JH, Hallgren KA, Tsui JI. mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with methamphetamine use and opioid use disorder. Addict Sci Clin Pract. 2025 Jan 29; 20(1):6. PMID: 39881397.
Read At: PubMed
- Published on 12/4/2024
Lewis N, Eggleston B, Chandler RK, Goddard-Eckrich D, Luster JE, Beard DD, Rodgers E, Chahine R, Westgate PM, Benjamin SN, Holloway J, Clarke T, Lefebvre RC, Stein MD, Helme DW, Reynolds J, Walsh SL, Freedman D, El-Bassel N, Stephens K, Silwal A, Lofwall M, Childerhose JE, Surratt HL, Crockett BN, Farmer AL, David JL, Fanucchi L, Harness J, Wilburn B, Bursey K, Mattson K, Mann S, Jackson RD, Shadwick A, Calver K, Chassler D, Kimball J, Regan N, Samet JH, Sword-Cruz R, Slater MD. Stigma and efficacy beliefs regarding opioid use disorder treatment and naloxone in communities participating in the HEALing Communities Study intervention. PLoS One. 2024; 19(12):e0308965. PMID: 39630633.
Read At: PubMed
- Published on 11/10/2024
Weinstein ZM, Yu O, Wartko PD, Samet JH, Bobb JF, Braciszewski JM, Arnsten JH, Murphy MT, Horigian VE, Stotts AL, Beers D, Bradley K. Does implementation of office based addiction treatment by a nurse care manager increase the duration of OUD treatment in primary care? A secondary analysis of the PROUD randomized control trial. Drug Alcohol Depend. 2024 Dec 01; 265:112497. PMID: 39550823.
Read At: PubMed
- Published on 11/7/2024
Lunze K, Carroll JJ, Ahuja N, Lira MC, Tsui JI, Ventura A, Colasanti JA, Liebschutz JM, Del Rio C, Samet JH. Opioid risk-reduction strategies for people with HIV on chronic opioid therapy: A qualitative study of patient perspectives. SSM Ment Health. 2024 Dec; 6. PMID: 39990723.
Read At: PubMed
- Published on 11/4/2024
Lapham GT, Hyun N, Bobb JF, Wartko PD, Matthews AG, Yu O, McCormack J, Lee AK, Liu DS, Samet JH, Zare-Mehrjerdi M, Braciszewski JM, Murphy MT, Arnsten JH, Horigian V, Caldeiro RM, Addis M, Bradley KA. Nurse Care Management of Opioid Use Disorder Treatment After 3 Years: A Secondary Analysis of the PROUD Cluster Randomized Clinical Trial. JAMA Netw Open. 2024 Nov 04; 7(11):e2447447. PMID: 39576637.
Read At: PubMed
- Published on 10/22/2024
Y Bernstein E, Magane KM, Dukes KA, Palfai TP, Lee JH, Saitz R, Samet JH. Correlates of post-hospitalization naltrexone adherence for alcohol use disorder. Drug Alcohol Depend. 2024 Dec 01; 265:112470. PMID: 39461121.
Read At: PubMed
View 476 more publications:View Full Profile at BUMC
News & In the Media
- Published on April 21, 2025
-
Published on June 17, 2024
Ambitious Federal Effort to Curb Overdoses Shows No Impact on Deaths, Initial Study Finds
- Published on March 22, 2023
- Published on May 11, 2020
- Published on October 16, 2019
- Published on August 23, 2019
-
Published on August 7, 2019
As Scotland’s ‘Trainspotting’ Generation Ages, the Dead Pile Up
- Published on June 5, 2019
- Published on June 5, 2019
- Published on April 25, 2019
-
Published on April 24, 2019
Greenfield, Montague, Athol and Orange to Join in $89M National Opioid Study
-
Published on October 31, 2018
In Massachusetts, Nearly 5 Percent of People Over 11 Abuse Opioids
-
Published on October 31, 2018
Study: Nearly 5 Percent of Mass. Residents Struggle with Opioid Abuse
-
Published on October 26, 2018
New Study Suggests Opioid Addiction in Mass. Is Much Worse Than Thought
-
Published on October 26, 2018
Study: 4.6 Percent of Massachusetts Population Has Opioid Use Disorder
-
Published on October 26, 2018
Study: Nearly 6% of Bristol County, Mass. Residents Addicted to Opioids
-
Published on October 26, 2018
In Massachusetts, Almost 1 in 20 Adults and Older Kids Abuse Opioids
-
Published on October 26, 2018
Study: 4.6 Percent of Massachusetts Residents Have Opioid Use Disorder
-
Published on October 26, 2018
Nearly 1 in 20 Massachusetts Residents Has Opioid Use Disorder
-
Published on October 1, 2018
Alcohol Use Disorder Therapy Could Improve Chronic Liver Disease Outcomes
-
Published on July 6, 2018
Leaders Call Restricting Methadone Treatment to Clinic Settings Outdated